0.0250
0.0000
(0.00%)
At close: January 8 at 2:55:20 PM EST
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-592.3300
-342.4180
-554.6830
-170.7760
-2,515.0270
Investing Cash Flow
--
--
-13.9990
-13.9980
261.9570
Financing Cash Flow
684.7230
684.7230
679.0000
250.0000
299.0000
End Cash Position
186.3560
716.9630
374.6580
264.3400
199.1140
Interest Paid Supplemental Data
--
--
2.3460
--
--
Capital Expenditure
--
--
--
--
-38.0430
Issuance of Capital Stock
--
--
90.0000
--
--
Issuance of Debt
--
200.0000
500.0000
250.0000
250.0000
Repayment of Debt
--
-200.0000
--
--
--
Free Cash Flow
-592.3300
-342.4180
-554.6830
-170.7760
-2,515.0270
1/31/2021 - 6/3/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SEOVF Sernova Corp.
0.1500
0.00%
CHGX.CN ChitogenX Inc.
0.0250
+66.67%
BIOV.CN BioVaxys Technology Corp.
0.0600
-7.69%
PMN ProMIS Neurosciences, Inc.
1.0300
+0.98%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
SVA.TO Sernova Corp.
0.2250
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
AADI Aadi Bioscience, Inc.
3.6000
0.00%
OGEN Oragenics, Inc.
0.3430
+2.82%
AUPH Aurinia Pharmaceuticals Inc.
8.07
-3.24%